A review of the current concerns about misconduct in medical sciences publications and the consequences
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Background In the new era of publication, scientific misconduct has become a focus of concern including extreme variability of plagiarism, falsification, fabrication, authorship issues, peer review manipulation, etc. Along with, overarching theme of "retraction" and "predatory journals" have emphasized the importance of studying related infrastructures.Methods Information used in this review was provided through accessing various databases as Google Scholar, Web of Science, Scopus, PubMed, Nature Index, Publication Ethics and Retraction Watch. Original researches, expert opinions, comments, letters, editorials, books mostly published between 2010 and 2020 were gathered and categorized into three sections of "Common types of misconduct"," Reasons behind scientific misconduct" and "Consequences". Within each part, remarkable examples from the past 10 years cited in Retraction Watch are indicated. At last, possible solution on combating misconduct are suggested.Results The number of publications are on the dramatic rise fostering a competition under which scholars are pushed to publish more. Consequently, due to several reasons including poor linguistic and illustration skills, not adequate evaluation, limited experience, etc. researchers might tend toward misbehavior endangering the health facts and ultimately, eroding country, journal/publisher, and perpetrator's creditability. The reported incident seems to be enhanced by the emergence of predatory with publishing about 8 times more papers in 2014 than which is in 2010. So that today, 65.3% of paper retraction is solely attributing to misconduct, with plagiarism at the forefront. As well, authorship issues and peer-review manipulation are found to have significant contribution besides further types of misconduct in this duration.Conclusion Given the expansion of the academic competitive environment and with the increase in research misconduct, the role of any regulatory sector, including universities, journals/publishers, government, etc. in preventing this phenomenon must be fully focused and fundamental alternation should be implemented in this regard.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inclusion of untrustworthy and potentially fraudulent trials in meta‐analyses and clinical guidelines may have serious implications for healthcare decisions that are informed by highly influential systematic reviews, including Cochrane reviews.”
From Trustworthiness assessment as an inclusion criterion for systematic reviews—What is the impact on results? (2023) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite the growing body of literature drawing attention to this issue, little action has been taken and large numbers of trials continue to be published that do not meet expected standards of conduct including lack of transparency, restricted access to data for external validation, and poor regulation and governance [1, 2, 3].”
From Trustworthiness assessment as an inclusion criterion for systematic reviews—What is the impact on results? (2023) · cites this paper as [1]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
11 retracted
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1806491 · Cited by 1,008
RetractedRETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis
Valastyan, S., Reinhardt, F., Benaich, N., Calogrias, D., Szász, A. M., Wang, Z. C., Brock, J. E., Richardson, A. L., & Weinberg, R. A. (2009) · Cell · doi:10.1016/j.cell.2009.03.047 · Cited by 820
RetractedIntegrative genomics identifies APOE ε4 effectors in Alzheimer's disease
Rhinn, H., Fujita, R., Qiang, L., Cheng, R., Lee, J. H., & Abeliovich, A. (2013) · Nature · doi:10.1038/nature12415 · Cited by 171
RetractedMyostatin is a novel tumoral factor that induces cancer cachexia
Lokireddy, S., Wijesoma, I. W., Bonala, S., Wei, M., Sze, S. K., McFarlane, C., Kambadur, R., & Sharma, M. (2012) · Biochemical Journal · doi:10.1042/bj20112024 · Cited by 102
RetractedRetraction Note: Integrative genomics identifies APOE ε4 effectors in Alzheimer’s disease
Rhinn, H., Fujita, R., Qiang, L., Chen, R., Lee, J. H., & Abeliovich, A. (2015) · Nature · doi:10.1038/nature14591 · Cited by 15
RetractedXu, L., Tang, H., El‐Naggar, A. K., Wei, P., & Sturgis, E. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128753 · Cited by 4
RetractedRetraction Note: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
Han, D. G., Habte, H. H., Qin, Y., Takamoto, K., LaBranche, C. C., Montefiori, D. C., & Cho, M. (2014) · Retrovirology · doi:10.1186/1742-4690-11-16 · Cited by 4
RetractedRETRACTED: A new technique for extraperitoneal repair of inguinal hernia
Xu, Q., Liu, S., Niu, J., et al. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.05.005 · Cited by 4
RetractedRetracted: Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
Han, D. G., Habte, H. H., Qin, Y., et al. (2012) · Retrovirology · doi:10.1186/1742-4690-9-s2-p362 · Cited by 2
RetractedRETRACTED ARTICLE: Image-based reversible data hiding algorithm toward big multimedia data
Xiong, C., Li, Y., Xiang, R., et al. (2018) · Multimedia Tools and Applications · doi:10.1007/s11042-017-5536-6 · Cited by 2
Retracted
Research works printed but not linked: 14
- Alison McCook. Springer, BMC retracting nearly 60 papers for fake reviews and other issues. 2016; Available from: http://retractionwatch.com/2016/11/01/springer-bmc-retracting-nearly-60-papers-for-fake-reviews-and-other-issues/.
- Alison McCook. A new way to fake authorship: submit under a prominent name, then say it was a mistake. 2016; Available from: https://retractionwatch.com/2016/11/28/new-way-fake-authorship-submit-prominent-name-say-mistake/.
- Ivan Oransky. Iranian mathematicians latest to have papers retracted for fake email addresses to get better reviews. 2012; Available from: https://retractionwatch.com/2012/09/24/iranian-mathematicians-latest-to-have-papers-retracted-for-fake-email-addresses-to-get-better-reviews/.
- Ivan Oransky. Retraction count grows to 35 for scientist who faked emails to do his own peer review. 2012; Available from: https://retractionwatch.com/2012/09/17/retraction-count-for-scientist-who-faked-emails-to-do-his-own-peer-review-grows-to-35/#more-9761.
- Dalmeet Singh Chawla. Medical journal retracts study over fake review, authorship concerns. 2016; Available from: https://retractionwatch.com/2016/11/02/medical-journal-retracts-study-over-fake-review-authorship-concerns/.
- Alison McCook. A journal waited 13 months to reject a submission. Days later, it published a plagiarized version by different authors. 2018; Available from: http://retractionwatch.com/2018/08/02/a-journal-waited-13-months-to-reject-a-submission-days-later-it-published-a-plagiarized-version-by-different-authors/.
- Angeli Mehta. Is publishing in the chemical sciences gender biased? 2019; Available from: https://www.chemistryworld.com/news/rsc-report-finds-publishing-pipeline-hinders-women/4010608.article.
- Alison McCook. How to spot a “citation cartel”. 2017; Available from: https://retractionwatch.com/2017/01/18/spot-citation-cartel/.
- McCook, A. Authorship for sale: some journals willing to add authors to papers they didn’t write. 2017; Available from: https://retractionwatch.com/2017/09/13/authorship-sale-journals-willing-add-authors-papers-didnt-write/.
- McCook, A. 7 signs a scientific paper’s authorship was bought. 2016; Available from: https://retractionwatch.com/2016/10/24/seven-signs-a-paper-was-for-sale/.
- McCook, A. Weizmann bans grad students from researcher’s lab over “serious misconduct”. 2017; Available from: http://retractionwatch.com/2017/07/19/weizmann-bans-grad-students-researchers-lab-serious-misconduct/.
- Andrew P. Han. New York psychiatry researcher charged with embezzlement, faces jail time. 2017; Available from: https://retractionwatch.com/2017/11/29/new-york-psychiatry-researcher-charged-embezzlement-faces-jail-time/.
- Megan Scudellari. Columbia biologists “deeply regret” nature retraction, after postdoc faked 74 panels in 3 papers. 2015; Available from: http://retractionwatch.com/2015/06/17/columbia-biologists-deeply-regret-nature-retraction-after-postdoc-faked-74-panels-in-3-papers/.
- Ivan Oransky. Journal retracts 16-year-old paper based on debunked autism-vaccine study. 2018; Available from: http://retractionwatch.com/2018/10/16/journal-retracts-16-year-old-paper-based-on-debunked-autism-vaccine-study/.
Cited by
Weeks, J., Cuthbert, A., & Alfirevic, Z. (2023) · Cochrane Evidence Synthesis and Methods · doi:10.1002/cesm.12037 · Cited by 42
Song, F., Wu, B., Wei, G., Cheng, S., Wei, L., Xiong, W., & Luo, D. (2025) · BMC Medicine · doi:10.1186/s12916-025-03965-8 · Cited by 7
Metadata
- Authors
- Mousavi, T., & Abdollahi, M.
- Affiliations
- Pharmaceutical Sciences Research Center (IR)
- Corresponding author
- Abdollahi, Mohammad
- Venue
- DARU Journal of Pharmaceutical Sciences
- Published
- 2020-02-19
- Volume
- 28
- Issue
- 1
- Pages
- 359-369
- ISSN
- 1560-8115 (ISSN-L)
- 2008-2231
- PMC
- PMC7214560
- OpenAlex
- W3008316822
- Cited by
- 57
- References
- 50
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 12 · 2023: 9 · 2022: 6 · 2021: 11 · 2020: 2
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- DARU Journal of Pharmaceutical Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Education › Academic integrity and plagiarism
- Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
- Social Sciences › Library and Information Sciences › Publishing and Scholarly Communication
- Keywords
- research misconduct, plagiarism, falsification, fabrication, authorship disputes, peer review manipulation, retraction, predatory journals, publication ethics, misconduct prevention
- MeSH terms
- Authorship, Books, Humans, Periodicals as Topic, Scientific Misconduct, Biomedical Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A review of the current concerns about misconduct in medical sciences publications and the consequences. https://app.cochat.ai/papers/10.1007/s40199-020-00332-1
- The paper
- Mousavi, T., & Abdollahi, M. (2020). A review of the current concerns about misconduct in medical sciences publications and the consequences. DARU Journal of Pharmaceutical Sciences. https://doi.org/10.1007/s40199-020-00332-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.